Attana’s presentation from Biotech Showcase 2022 is now available on Attana’s website
January 10–19, Attana is participating in one of the largest biotech conferences in the world – Biotech Showcase. Attana is attending the digital conference and have published a presentation as well as participated in digital one-to-one meetings.
The presentation was held in English and primarily focused on Attana’s ongoing diagnostic work and its two business units – Life Science and Diagnostics.
The presentation can be accessed on Attana’s website by following this link:
For more information, please contact:
Teodor Aastrup, CEO
+46 (0)8 674 57 00
The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.
Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact firstname.lastname@example.org